In a paper published by the research team of Ali Hafezi-Moghadam, MD, PhD at the Brigham and Women’s Hospital (BWH), a founding member of Mass General Brigham, authors introduced a biodegradable ...

A team of Google researchers has published a paper in the Journal of the American Medical Association showing that Google's deep learning algorithm, trained on a large data set of fundus images, can ...

Despite its underutilization, AI-powered diabetic retinopathy screening was associated with greater OCT referral rates than traditional screening methods. Artificial intelligence (AI)-based diabetic ...

Only a small proportion of patients with diabetes have undergone artificial intelligence (AI)–based screening for diabetic retinopathy since 2021, despite approval from the US Food and Drug ...

Diabetes is often called a silent disease and nowhere is this more evident than in the eyes. Many people assume vision problems occur only later in life, but diabetic eye damage can begin much earlier ...

Please provide your email address to receive an email when new articles are posted on . Ford Medical will distribute AEYE-DS to U.S. pharmacies and non-acute centers. The system pairs with a retinal ...

This story is part of a series on the current progression in Regenerative Medicine. This piece is part of a series dedicated to the eye and improvements in restoring vision. This piece also marks part ...

Julie Rodman, OD, MS, FAAO, discusses how optical coherence tomography angiography (OCT-A) can be used to diagnose and manage diabetic retinopathy. Julie Rodman, OD, MS, FAAO, clinic chief at Nova ...

While artificial intelligence (AI)-assisted detection of diabetic retinopathy has the potential to expand access to screening, few patients with diabetes have been evaluated with the technology since ...

Editor’s note: This is an automatically generated transcript, which has been slightly edited for clarity. Please notify editor@healio.com if there are concerns regarding accuracy of the transcription.